Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes

Early detection and management of gestational diabetes (GDM) benefits both mother and infants. For women with early GDM, Dexcom CGM improved maternal and neonatal complications, including lower unscheduled caesarean sections, preterm deliveries, large-for-gestational age neonates, and NICU admissions, compared to self-monitoring of blood glucose (SMBG).